Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.

Al-Hakim A. et al, (2025), Lancet Rheumatol

The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health

Dyson ZA. et al, (2025), Genome Medicine, 17

BactiVac, the Bacterial Vaccines Network.

MacLennan CA. et al, (2025), Vaccine, 57

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.

Ibarz-Pavon AB. et al, (2025), Vaccine, 56

Landscape analysis of invasive non-typhoidal salmonella (iNTS) disease and iNTS vaccine use case and demand: Report of a WHO expert consultation.

Emary K. et al, (2025), Vaccine, 55

Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population.

Faustini SE. et al, (2024), The Journal of infection, 89

Evaluation of a Quadrivalent <i>Shigella flexneri</i> Serotype 2a, 3a, 6, and <i>Shigella sonnei</i> O-Specific Polysaccharide and IpaB MAPS Vaccine.

Boerth EM. et al, (2024), Vaccines, 12

Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study.

Vannice K. et al, (2024), Open forum infectious diseases, 11, S1 - S5

IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents.

Asato V. et al, (2024), Vaccines, 12

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.

Giersing BK. et al, (2023), The Lancet. Global health, 11, e1819 - e1826

The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.

Baqar S. et al, (2023), Vaccine

A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.

Van Puyvelde S. et al, (2023), Nat Commun, 14

Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A.

Boerth EM. et al, (2023), Vaccines, 11

Salmonella Combination Vaccines: Moving Beyond Typhoid

MacLennan CA. et al, (2023), Open Forum Infectious Diseases, 10, S58 - S66

Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli.

Beriotto I. et al, (2023), Microbiology spectrum, 11

Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections

Abuga KM. et al, (2023), Wellcome Open Research, 8, 48 - 48

Consequences of Shigella infection in young children: a systematic review.

Libby TE. et al, (2023), Int J Infect Dis

Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum.

Elias SC. et al, (2023), Heliyon, 9

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.

Micoli F. et al, (2023), Frontiers in molecular biosciences, 10

Immune responses to Neisseria gonorrhoeae and implications for vaccine development.

Belcher T. et al, (2023), Frontiers in immunology, 14

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?